Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, MAT

PURA Patented and Research Backed CBD Gummies Standout in $6.94 Billion Market


DALLAS, April 24, 2020 /PRNewswire/ -- Puration, Inc. (USOTC: PURA) today reports on its continuing progress in the rebranding of its recently acquired Hemp4mula CBD confections business that includes CBD infused gummies and gum. Grand View Research, Inc. recently reported that the global CBD gummies market is expected to reach $6.94 Billion by 2025. Puration's rebranding strategy centers on emphasizing the U.S. Patent and extensive university medical research backing Puration's gummies and gum.  Puration has the only license of the NCM Biotech patented extraction process. NCM Biotech is focused on medical research and Puration has access to that research. The benefits of the rebranded Hemp4mula gummies and gum will be backed by NCM Biotech's patented extraction process and university medical research making Puration's gummies and gum a standout in the global market.

See a recent research report on CBD extracts derived from NCM Biotech's patented extraction process: Journal of Cannabis Research

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor: 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. 

Contact:

Puration, Inc.
Brian Shibley,
[email protected]
(800) 861-1350

 

 

 

SOURCE Puration, Inc.


These press releases may also interest you

at 18:13
Appsketiers Empowers Aspiring Entrepreneurs with Affordable, Custom App Development, Offering Unmatched Starting Prices
In a digital era where the app market continues to expand, driven by increased smartphone adoption and technological advancements, Appsketiers emerges as a beacon of hope for aspiring entrepreneurs and innovators. With a mission to democratize app...

at 18:00
Voxtur Engages ICP Securities Inc. for Automated Market Making Services
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...

at 18:00
Portland General Electric declares dividend
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis. The company's dividend is...

at 17:55
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:48
TCTM Filed 2023 Annual Report on Form 20-F
TCTM Kids IT Education Inc. ("TCTM" or the "Company"), a leading provider of IT-focused supplementary STEM education services in China, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with...

at 17:21
Data Warehouse as a Service Market size to increase by USD 7.91 bilion between 2022 to 2027, Market Segmentation by End-user and Geography, Technavio
The global data warehouse as a service market size is estimated to grow by USD 7915.19 mn from 2023 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 21.09% during the forecast period. The Data Warehouse as a Service...

More news about Science and technology...


News published on and distributed by: